{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:17:58Z","timestamp":1785403078286,"version":"3.56.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is no consensus on the efficacy of Bacillus Calmette\u2013Gu\u00e9rin (BCG) revaccination. Because of this, we aimed to compare the effect of BCG revaccination with no revaccination in preventing tuberculosis (TB) disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched PubMed, Embase, and the Cochrane Library databases from inception to December of 2023 for studies that compared BCG revaccination with no revaccination or placebo for this systematic review and meta-analysis. Outcomes of interest were incidence of TB disease, pulmonary TB and extrapulmonary TB. We pooled odds ratios (ORs) with 95% confidence interval (CI) using a random-effects model in R statistical software version 4.3.1. Heterogeneity was assessed with I2 statistics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five studies, involving 1\u00a0012\u00a0007 patients, of whom 501\u00a0597 (49.56%) were revaccinated with BCG, were included in the meta-analysis. There was a benefit in tuberculosis disease incidence in patients who received revaccination compared to patients who did not (OR 0.89; 95% CI: 0.81\u20130.98; P\u2009=\u2009.019; I2 = 53%) in the randomized controlled trials. When including observational studies, we found the same trend (OR 0.90; 95% CI: 0.77\u20131.05; P\u2009=\u2009.124; I2 = 26%) as well as in preventing against both extrapulmonary (OR 0.82; 95% CI: 0.38\u20131.76; P\u2009=\u2009.375; I2 = 24%) and pulmonary (OR 0.93; 95% CI: 0.86\u20131.01; P\u2009=\u2009.062; I2 = 0%) cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>BCG revaccination was associated with a slight decrease in the incidence of tuberculosis, pulmonary tuberculosis, and extrapulmonary tuberculosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ije\/dyaf186","type":"journal-article","created":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T08:50:36Z","timestamp":1762678236000},"source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of Bacillus Calmette\u2013Gu\u00e9rin revaccination in preventing tuberculosis disease: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0341-0642","authenticated-orcid":false,"given":"Yohanna Idsabella","family":"Rossi","sequence":"first","affiliation":[{"name":"Federal University of Health Sciences of Porto Alegre (UFCSPA) , Porto Alegre CEP 90050-170,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Bolner","sequence":"additional","affiliation":[{"name":"Federal University of Health Sciences of Porto Alegre (UFCSPA) , Porto Alegre CEP 90050-170,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Dolovitsch de Oliveira","sequence":"additional","affiliation":[{"name":"Federal University of Health Sciences of Porto Alegre (UFCSPA) , Porto Alegre CEP 90050-170,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Costa Dall\u2019Acqua","sequence":"additional","affiliation":[{"name":"Federal University of Health Sciences of Porto Alegre (UFCSPA) , Porto Alegre CEP 90050-170,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e2nio","family":"Antunes do Livramento Junior","sequence":"additional","affiliation":[{"name":"Federal University of Health Sciences of Porto Alegre (UFCSPA) , Porto Alegre CEP 90050-170,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00edcero Arm\u00eddio Gomes","family":"Dias","sequence":"additional","affiliation":[{"name":"Federal University of Health Sciences of Porto Alegre (UFCSPA) , Porto Alegre CEP 90050-170,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"2025110903503240000_dyaf186-B1","volume-title":"Global Tuberculosis Report 2023","author":"World Health Organization","year":"2023"},{"key":"2025110903503240000_dyaf186-B2","author":"World Health Organization"},{"key":"2025110903503240000_dyaf186-B3","doi-asserted-by":"crossref","first-page":"g4643","DOI":"10.1136\/bmj.g4643","article-title":"Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis","volume":"349","author":"Roy","year":"2014","journal-title":"BMJ"},{"key":"2025110903503240000_dyaf186-B4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1164\/rccm.201201-0026OC","article-title":"Identifying predictors of interferon-\u03b3 release assay results in pediatric latent tuberculosis: a protective role of Bacillus calmette-Gu\u00e9rin?","volume":"186","author":"Basu Roy","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2025110903503240000_dyaf186-B5","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0140-6736(05)67534-4","article-title":"Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study","volume":"366","author":"Soysal","year":"2005","journal-title":"Lancet"},{"key":"2025110903503240000_dyaf186-B6","doi-asserted-by":"crossref","first-page":"e1001012","DOI":"10.1371\/journal.pmed.1001012","article-title":"The BCG World Atlas: a database of global BCG vaccination policies and practices","volume":"8","author":"Zwerling","year":"2011","journal-title":"PLoS Med"},{"key":"2025110903503240000_dyaf186-B7","first-page":"73","article-title":"BCG vaccines: WHO position paper\u2014February 2018","volume":"93","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"2025110903503240000_dyaf186-B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17370","article-title":"Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Gu\u00e9rin vaccination against tuberculosis","volume":"17","author":"Abubakar","year":"2013","journal-title":"Health Technol Assess"},{"key":"2025110903503240000_dyaf186-B9","first-page":"536","article-title":"A case-control study of protection against tuberculosis by BCG revaccination in Recife, Brazil","volume":"10","author":"Dantas","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025110903503240000_dyaf186-B10","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1164\/ajrccm.157.4.9706037","article-title":"Bacillus calmette-Gu\u00e9rin revaccination questionable with low tuberculosis incidence","volume":"157","author":"Tala-Heikkil\u00e4","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"2025110903503240000_dyaf186-B11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4103\/ijmr.ijmr_1540_22","article-title":"Revisiting the Chingleput BCG vaccination trial for the impact of BCG revaccination on the incidence of tuberculosis disease","volume":"157","author":"Velayutham","year":"2023","journal-title":"Indian J Med Res"},{"key":"2025110903503240000_dyaf186-B12","doi-asserted-by":"crossref","first-page":"e1451\u20139","DOI":"10.1016\/S2214-109X(21)00309-0","article-title":"BCG re-vaccination in Malawi: 30-year follow-up of a large, randomised, double-blind, placebo-controlled trial","volume":"9","author":"Glynn","year":"2021","journal-title":"Lancet Glob Health"},{"key":"2025110903503240000_dyaf186-B13","doi-asserted-by":"publisher","first-page":"656","DOI":"10.4172\/scientificreports.65","article-title":"Bacille Calmette-Guerin (BCG) revaccination: is it beneficial for tuberculosis control?","volume":"2","author":"Ahmad","year":"2013","journal-title":"OMICS International"},{"key":"2025110903503240000_dyaf186-B14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"2025110903503240000_dyaf186-B15","author":"Higgins","year":"2023"},{"key":"2025110903503240000_dyaf186-B16","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2025110903503240000_dyaf186-B17","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"2025110903503240000_dyaf186-B18","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"2025110903503240000_dyaf186-B19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"2025110903503240000_dyaf186-B20","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2023"},{"key":"2025110903503240000_dyaf186-B21","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1177\/21925682221110527","article-title":"Fixed-effect vs random-effects models for meta-analysis: 3 points to consider","volume":"12","author":"Dettori","year":"2022","journal-title":"Global Spine J"},{"key":"2025110903503240000_dyaf186-B22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jrsm.1216","article-title":"Accounting for heterogeneity in meta-analysis using a multiplicative model-an empirical study: accounting for heterogeneity in meta-analysis","volume":"8","author":"Mawdsley","year":"2017","journal-title":"Res Synth Methods"},{"key":"2025110903503240000_dyaf186-B23","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1016\/j.vaccine.2011.05.023","article-title":"Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial","volume":"29","author":"Barreto","year":"2011","journal-title":"Vaccine"},{"key":"2025110903503240000_dyaf186-B24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M. tuberculosis infection with H4: IC31 vaccine or BCG revaccination","volume":"379","author":"Nemes","year":"2018","journal-title":"N Engl J Med"},{"key":"2025110903503240000_dyaf186-B25","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0197-2456(02)00216-7","article-title":"Design of the Brazilian BCG-REVAC trial against tuberculosis","volume":"23","author":"Barreto","year":"2002","journal-title":"Control Clin Trials"},{"key":"2025110903503240000_dyaf186-B26","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial","volume":"366","author":"Rodrigues","year":"2005","journal-title":"Lancet"},{"key":"2025110903503240000_dyaf186-B27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2288-7-11","article-title":"Selection bias: neighbourhood controls and controls selected from those presenting to a Health Unit in a case control study of efficacy of BCG revaccination","volume":"7","author":"Dantas","year":"2007","journal-title":"BMC Med Res Methodol"},{"key":"2025110903503240000_dyaf186-B28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/ijmr.ijmr_382_23","article-title":"The prevalence of tuberculosis infection in India: a systematic review and meta-analysis","volume":"157","author":"Chauhan","year":"2023","journal-title":"Indian J Med Res"},{"key":"2025110903503240000_dyaf186-B29","volume-title":"Health Sector Priorities Review: Tuberculosis. Disease Control Priorities in Developing Countries","author":"Murray","year":"1991"},{"key":"2025110903503240000_dyaf186-B30","author":"Mahasha","year":"2018"},{"key":"2025110903503240000_dyaf186-B31","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/jama.1995.03520270054031","article-title":"Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic","volume":"273","author":"Raviglione","year":"1995","journal-title":"JAMA"},{"key":"2025110903503240000_dyaf186-B32","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"2025110903503240000_dyaf186-B33","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1172\/JCI133935","article-title":"BCG vaccination in humans inhibits systemic inflammation in a sex-dependent manner","volume":"130","author":"Koeken","year":"2020","journal-title":"J Clin Invest"},{"key":"2025110903503240000_dyaf186-B34","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/infdis\/jix612","article-title":"Rapid protective effects of early BCG on neonatal mortality among low birth weight boys: Observations from randomized trials","volume":"217","author":"Biering-S\u00f8rensen","year":"2018","journal-title":"J Infect Dis"},{"key":"2025110903503240000_dyaf186-B35","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/01.inf.0000145700.77286.94","article-title":"Hepatitis B vaccination associated with higher female than male mortality in Guinea-Bissau: an observational study","volume":"23","author":"Garly","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"2025110903503240000_dyaf186-B36","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/JLB.5MA0118-027R","article-title":"The impact of sex hormones on BCG-induced trained immunity","volume":"104","author":"de Bree","year":"2018","journal-title":"J Leukoc Biol"},{"key":"2025110903503240000_dyaf186-B37","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1016\/j.vaccine.2006.03.038","article-title":"Age-specific changes in the female-male mortality ratio related to the pattern of vaccinations: an observational study from rural Gambia","volume":"24","author":"Aaby","year":"2006","journal-title":"Vaccine"},{"key":"2025110903503240000_dyaf186-B38","first-page":"185","article-title":"The efficacy of Bacillus Calmette-Guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly","volume":"43","author":"Datau","year":"2011","journal-title":"Acta Med Indones"},{"key":"2025110903503240000_dyaf186-B39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cell.2020.08.051","article-title":"Activate: randomized clinical trial of BCG vaccination against infection in the elderly","volume":"183","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell"},{"key":"2025110903503240000_dyaf186-B40","doi-asserted-by":"crossref","first-page":"632478","DOI":"10.3389\/fimmu.2021.632478","article-title":"The BCG vaccine for COVID-19: first verdict and future directions","volume":"12","author":"Gonzalez-Perez","year":"2021","journal-title":"Front Immunol"},{"key":"2025110903503240000_dyaf186-B41","doi-asserted-by":"crossref","first-page":"100073","DOI":"10.1016\/j.xcrm.2020.100073","article-title":"Safety and COVID-19 symptoms in individuals recently vaccinated with BCG: a retrospective cohort study","volume":"1","author":"Moorlag","year":"2020","journal-title":"Cell Rep Med"},{"key":"2025110903503240000_dyaf186-B42","doi-asserted-by":"crossref","first-page":"eabg7181","DOI":"10.1126\/sciadv.abg7181","article-title":"Effect of BCG vaccination on proinflammatory responses in elderly individuals","volume":"7","author":"Pavan Kumar","year":"2021","journal-title":"Sci Adv"},{"key":"2025110903503240000_dyaf186-B43","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijid.2021.07.041","article-title":"BCG vaccination induces enhanced frequencies of dendritic cells and altered plasma levels of type I and type III interferons in elderly individuals","volume":"110","author":"Kumar","year":"2021","journal-title":"Int J Infect Dis"}],"container-title":["International Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ije\/article-pdf\/54\/6\/dyaf186\/65240568\/dyaf186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ije\/article-pdf\/54\/6\/dyaf186\/65240568\/dyaf186.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T08:50:43Z","timestamp":1762678243000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ije\/article\/doi\/10.1093\/ije\/dyaf186\/8316720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,10,14]]}},"URL":"https:\/\/doi.org\/10.1093\/ije\/dyaf186","relation":{},"ISSN":["0300-5771","1464-3685"],"issn-type":[{"value":"0300-5771","type":"print"},{"value":"1464-3685","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,10,14]]},"article-number":"dyaf186"}}